Roivant Sciences Ltd. Insider Trading Update
Ticker: ROIV · Form: 4 · Filed: Apr 21, 2026 · CIK: 0001635088
| Field | Detail |
|---|---|
| Company | Roivant Sciences Ltd. (ROIV) |
| Form Type | 4 |
| Filed Date | Apr 21, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-trading, form-4, ownership-change
Related Tickers: ROIV
TL;DR
Momtazee filed a Form 4 for ROIV. Details TBD.
AI Summary
On April 17, 2026, James C. Momtazee reported a change in beneficial ownership of securities for Roivant Sciences Ltd. The filing details transactions related to his holdings, but specific dollar amounts and the exact nature of the transactions are not provided in this excerpt.
Why It Matters
Insider transactions can signal management's confidence in the company's future prospects, potentially influencing investor sentiment.
Risk Assessment
Risk Level: medium — Form 4 filings indicate insider activity, which can be a mixed signal depending on the nature of the transaction.
Key Numbers
- 2026-04-17 — Period of Report (Date of reported transactions)
- 2026-04-21 — Filing Date (Date the form was submitted to the SEC)
Key Players & Entities
- Roivant Sciences Ltd. (company) — Issuer
- James C. Momtazee (person) — Reporting Person
- 0001635088 (company_id) — Roivant Sciences Ltd. CIK
- 0001209181-26-000003 (filing_id) — SEC Accession Number
FAQ
Who is the reporting person in this filing?
James C. Momtazee is the reporting person.
What company is this filing related to?
This filing is related to Roivant Sciences Ltd.
What type of form is this?
This is a Form 4, a Statement of changes in beneficial ownership of securities.
What is the period of report for this filing?
The period of report is April 17, 2026.
When was this filing accepted by the SEC?
This filing was accepted on April 21, 2026.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 21, 2026 by James C. Momtazee regarding Roivant Sciences Ltd. (ROIV). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.